Literature DB >> 23558763

Neurally adjusted ventilatory assist in non-invasive ventilation.

C Sinderby1, J Beck.   

Abstract

This manuscript describes the motivation for developing neurally adjusted ventilatory assist (NAVA) and its subsequent use with a non-invasive interface. The challenges with conventional, pneumatically controlled non-invasive modes are briefly described, followed by a mini-review on the upper airways and the diaphragm electrical activity (EAdi) signal. The bulk of the review focuses on the importance and use of monitoring the EAdi during non-invasive ventilation, and a report of the recent experimental and clinical findings with NAVA during non-invasive ventilation. In summary, non-invasive NAVA provides a truly synchronized mode of non-invasive ventilation, both in time and in level of assist. Along with EAdi monitoring, NAVA can increase the confidence to treat respiratory failure non-invasively.

Entities:  

Mesh:

Year:  2013        PMID: 23558763

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  4 in total

1.  Lung protection during non-invasive synchronized assist versus volume control in rabbits.

Authors:  Lucia Mirabella; Giacomo Grasselli; Jack J Haitsma; Haibo Zhang; Arthur S Slutsky; Christer Sinderby; Jennifer Beck
Journal:  Crit Care       Date:  2014-01-23       Impact factor: 9.097

2.  Diaphragm-triggered non-invasive respiratory support in preterm infants.

Authors:  Dimple Goel; Ju Lee Oei; John Smyth; Tim Schindler
Journal:  Cochrane Database Syst Rev       Date:  2020-03-17

3.  Noninvasive Neurally Adjusted Ventilator Assist Ventilation in the Postoperative Period Produces Better Patient-Ventilator Synchrony but Not Comfort.

Authors:  L O Harnisch; U Olgemoeller; J Mann; M Quintel; O Moerer
Journal:  Pulm Med       Date:  2020-06-20

4.  Multichannel esophageal signals to monitor respiratory rate in preterm infants.

Authors:  Corine Bürgin; Patrizia Simmen; Nishant Gupta; Lilian Suter; Samuel Kreuzer; Andreas Haeberlin; Sven M Schulzke; Daniel Trachsel; Thomas Niederhauser; Kerstin Jost
Journal:  Pediatr Res       Date:  2021-10-02       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.